Select a Company
9.13 EGP -0.43 (-4.50%)
As of 02-Apr-2020
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products. In addition, it manufactures and distributes several other licensed products from other companies.
Glaxo Smith Kline
9.13 EGP -0.43 (-4.50%)As of 02-Apr-2020
| Sector Health Care | Industry Pharmaceuticals & Biotechnology |
| Symbol BIOC | ISIN EGS38171C012 |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products. In addition, it manufactures and distributes several other licensed products from other companies.
Website: www.gsk.com
Unlock The All New Company Profiles with our BASIC subscription plan
Detailed company overview Interactive Chart Market Activity: share price performance, market cap, volume, turnover, etc .. Dividend history Corporate actions 17 markets & 1400+ listed companies
You will also enjoy some exclusive features of African-markets.com including our Premium stories and research papers. Click here for a sample company profile.
|
UPCOMING EVENTS
https://www.african-markets.com/images/ju_cached_images/AIS2018-Square_411ad77434821170d1f5e8960525d272_90x50.resized.jpg
